- Home
- SFBS vs ALKS Comparison
SFBS vs ALKS Comparison
Compare SFBS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFBS
- ALKS
- Stock Information
- Founded
- SFBS 2005
- ALKS 1987
- Country
- SFBS United States
- ALKS Ireland
- Employees
- SFBS N/A
- ALKS N/A
- Industry
- SFBS Major Banks
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- SFBS Finance
- ALKS Health Care
- Exchange
- SFBS Nasdaq
- ALKS Nasdaq
- Market Cap
- SFBS 4.6B
- ALKS 4.9B
- IPO Year
- SFBS 2014
- ALKS 1991
- Fundamental
- Price
- SFBS N/A
- ALKS $31.51
- Analyst Decision
- SFBS Hold
- ALKS Strong Buy
- Analyst Count
- SFBS 1
- ALKS 14
- Target Price
- SFBS $90.00
- ALKS $41.43
- AVG Volume (30 Days)
- SFBS 241.5K
- ALKS 1.8M
- Earning Date
- SFBS 10-20-2025
- ALKS 10-23-2025
- Dividend Yield
- SFBS 1.64%
- ALKS N/A
- EPS Growth
- SFBS 26.23
- ALKS 21.99
- EPS
- SFBS 4.57
- ALKS 2.08
- Revenue
- SFBS $488,391,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- SFBS $26.57
- ALKS N/A
- Revenue Next Year
- SFBS $15.44
- ALKS $1.59
- P/E Ratio
- SFBS $17.86
- ALKS $15.16
- Revenue Growth
- SFBS 18.16
- ALKS N/A
- 52 Week Low
- SFBS $66.48
- ALKS $25.17
- 52 Week High
- SFBS $101.37
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- SFBS 48.21
- ALKS 63.86
- Support Level
- SFBS $78.12
- ALKS $30.70
- Resistance Level
- SFBS $83.51
- ALKS $31.68
- Average True Range (ATR)
- SFBS 1.65
- ALKS 0.77
- MACD
- SFBS -0.08
- ALKS 0.32
- Stochastic Oscillator
- SFBS 53.31
- ALKS 86.41
About SFBS ServisFirst Bancshares Inc.
Servisfirst Bancshares Inc is a bank holding company whose business is conducted by its wholly owned subsidiary, ServisFirst Bank. Through the bank, it offers various banking services to individual and corporate customers in Birmingham, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. Its various products and service offerings include commercial, consumer, and other loans; accepting deposits; providing electronic banking services, such as online and mobile banking, including remote deposit capture; delivering treasury and cash management services; and providing banking services to other financial institutions. The company operates as a single reportable segment, with a majority of its revenue being derived from the business of banking.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.